10-Q: Ingevity Reports Q2 Loss, Boosted by Repositioning
Quarterly Report
Ingevity Corporation reported a reduced net loss in Q2 2025, driven by strategic repositioning efforts and improved cash flow, despite a significant goodwill impairment in its Advanced Polymer Technologies segment.
Summary
- Reported a net loss of $(146.5) million for Q2 2025, an improvement from $(283.7) million in Q2 2024.
- Net sales declined by 9% to $365.1 million in Q2 2025, primarily due to reduced performance in the Performance Chemicals segment and weaker customer demand in Advanced Polymer Technologies.
- Gross profit increased by $14.7 million in Q2 2025, driven by favorable pricing and sales mix, decreased manufacturing costs, and a LIFO liquidation benefit of $4.1 million.
- Recorded a non-cash goodwill impairment charge of $183.8 million in the Advanced Polymer Technologies segment for Q2 2025 due to international tariffs and macroeconomic factors.
- Adjusted EBITDA increased to $110.0 million in Q2 2025 from $101.3 million in Q2 2024.
- Net cash provided by operating activities significantly improved to $104.4 million for the six months ended June 30, 2025, compared to $17.6 million in the prior year period.
- Reaffirmed 2025 Net sales outlook of $1.25 billion to $1.4 billion and revised the Adjusted EBITDA outlook upwards to $390 million to $415 million.
- The Performance Chemicals segment repositioning efforts have resulted in $103 million in total cash savings and $12 million in non-cash savings since November 2023.
- Accrued $93.4 million for the BASF lawsuit verdict and post-judgment interest as of June 30, 2025, with final resolution expected within 12 months.
Sentiment
Score: 6
Explanation: The sentiment is cautiously positive. While the company reported a net loss and a significant goodwill impairment in one segment, the reduction in the net loss, substantial improvement in Adjusted EBITDA and cash flow from operations, and the upward revision of the full-year EBITDA outlook indicate positive momentum from strategic repositioning efforts. However, ongoing sales declines, segment-specific challenges, and a large legal liability temper the overall positive outlook.
Positives
- Net loss significantly reduced to $(146.5) million in Q2 2025 from $(283.7) million in Q2 2024.
- Adjusted EBITDA increased by $8.7 million to $110.0 million in Q2 2025, and by $25.6 million to $201.3 million for the six months ended June 30, 2025.
- Net cash provided by operating activities surged to $104.4 million for the six months ended June 30, 2025, a substantial increase from $17.6 million in the prior year.
- Performance Chemicals segment EBITDA improved significantly to $31.7 million for the six months ended June 30, 2025, from a loss of $(1.3) million in the prior year, driven by repositioning actions and lower raw material costs.
- Realized $103 million in total cash savings and $12 million in non-cash savings from the Performance Chemicals repositioning since November 2023.
- Full-year 2025 Adjusted EBITDA outlook was revised upwards to between $390 million and $415 million.
- Maintained strong liquidity with $76.9 million in cash and $400.0 million undrawn capacity on the revolving credit facility.
- In compliance with all debt covenants, with a net leverage ratio of 2.9 and interest coverage ratio of 5.0.
Negatives
- Net sales declined by 9% in Q2 2025 to $365.1 million and by 11% for the six months ended June 30, 2025, to $649.1 million, primarily due to volume declines.
- Advanced Polymer Technologies (APT) segment experienced a significant non-cash goodwill impairment charge of $183.8 million in Q2 2025 due to international tariffs and weaker demand.
- APT segment Net sales decreased by 10% in Q2 2025 and Segment EBITDA decreased by 91% due to a planned extended outage and tariff-related pressures.
- The company faces a substantial accrued liability of $93.4 million for the BASF lawsuit verdict and post-judgment interest.
- Performance Materials segment EBITDA decreased by $5.1 million in Q2 2025 due to lower net sales, investments in innovation, and one-time employee compensation costs.
- Increased selling, general, and administrative expenses in Q2 2025 due to higher variable incentive compensation and commercial activities spending.
Risks
- International tariffs and global trade tensions negatively impacting business, particularly Advanced Polymer Technologies, and potentially leading to increased prices or reduced demand.
- Exposure to risks related to international sales and operations, including changes in tariffs.
- Adverse conditions in the automotive market may continue to negatively impact demand for automotive carbon products.
- Competition from substitute products, new technologies, and new or emerging competitors.
- Adverse conditions in cyclical end markets may continue to adversely affect demand for products.
- Lack of access to raw materials, particularly Crude Tall Oil (CTO), could impact production, although exposure has been reduced.
- Disruptions at manufacturing facilities due to natural disasters, extreme weather, labor difficulties (including potential work stoppages from expiring collective bargaining agreements), equipment failure, or unscheduled maintenance.
- Dependence on attracting and retaining key personnel.
- Dependence on certain large customers.
- Ongoing legal actions associated with intellectual property rights, including the BASF lawsuit, which has an accrued liability of $93.4 million and is under appeal.
- Inability to protect intellectual property and other proprietary information could lead to competitive disadvantage.
- Information technology security breaches and other disruptions.
- Government policies and regulations, including those affecting the environment, climate change, tax policies, tariffs, and the chemicals industry, may adversely affect financial results.
- Losses due to lawsuits arising from environmental damage or personal injuries associated with chemical or other manufacturing processes.
Future Outlook
The company reaffirmed its 2025 Net sales outlook between $1.25 billion and $1.4 billion, expecting Performance Materials sales to be similar to the prior year due to a projected 4% decline in North America light vehicle production. Performance Chemicals' road technologies product line is anticipated to see modest growth, with industrial specialties projected to deliver Net sales between $160 million and $200 million. Advanced Polymer Technologies' Net sales are expected to be down mid-to-high single digits due to weaker end-market demand, tariffs, and competitive pressures. The Adjusted EBITDA outlook for 2025 was revised upwards to between $390 million and $415 million, driven by improved profitability in Performance Chemicals and current light vehicle production forecasts. Performance Materials segment EBITDA margins are expected to remain around 50%, while Performance Chemicals segment EBITDA margins are anticipated to be in the high-single to low-double digits, and Advanced Polymer Technologies segment EBITDA margins in the mid-teens to low-twenty percent range.
Management Comments
- We continue to closely monitor the evolving macroeconomic environment, including the impacts of recent tariffs and ongoing trade uncertainty.
- Despite these challenges, we are reaffirming our prior 2025 outlook for Net sales between $1.25 billion and $1.4 billion.
- The Performance Chemicals repositioning, which began in November 2023, is focused on reducing exposure to lower margin end-use markets of our industrial specialties product line, such as adhesives, publication inks, and oilfield, representing approximately 45 percent of our industrial specialties product line historical annualized net sales.
- We expect Adjusted EBITDA to be between $390 million and $415 million.
- Should the forecasted ~4 percent reduction in North America light vehicle production versus 2024 materialize, we anticipate EBITDA in our Performance Materials reportable segment will decline compared to the prior year.
- We expect to maintain Performance Materials segment EBITDA margins of around 50%, supported by improved pricing and continued operational efficiencies.
- In our Performance Chemicals reportable segment, we expect segment EBITDA to improve, driven by modest revenue growth in our road technologies product line, lower CTO input costs, and the benefits of successfully executed repositioning actions.
- We anticipate Performance Chemicals segment EBITDA margins to be in the high-single to low-double digits.
- For our Advanced Polymer Technologies reportable segment, as a result of expected weaker end-market demand impacting volumes, segment EBITDA margins are expected to be in the mid-teens to-low twenty percent range.
Industry Context
The company's performance is influenced by broader industry trends, including global trade tensions and international tariffs, which have negatively impacted the Advanced Polymer Technologies segment. Unusually wet weather in the U.S. has delayed road construction projects, affecting the Performance Chemicals' road technologies product line. The automotive market's adverse conditions, with a projected ~4% decline in North America light vehicle production for 2025, are expected to impact the Performance Materials segment. The company is strategically repositioning its Performance Chemicals segment to reduce cyclicality by diversifying its raw material stream to non-Crude Tall Oil (CTO) based fatty acids and focusing on higher-margin product lines.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Employee | S. Edward Woodcock | N/A | 2025-07-01 | Termination of employment via separation agreement. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| New Incentive Plan | Grant of performance-based Restricted Stock Unit Awards under the Ingevity Corporation 2025 Omnibus Incentive Plan for U.S. and U.K. employees. | 2025-04-29 | Aligns executive compensation with performance goals (EBITDA growth and total stockholder return) over a multi-year period, incentivizing long-term value creation. |
| New Incentive Plan | Grant of service-based Restricted Stock Unit Awards under the Ingevity Corporation 2025 Omnibus Incentive Plan for U.S. and U.K. employees. | 2025-04-29 | Provides service-based equity incentives, promoting employee retention and alignment with shareholder interests. |
| New Incentive Plan | Grant of performance-based and service-based cash awards under the Ingevity Corporation 2025 Omnibus Incentive Plan for International Participants. | 2025-04-29 | Extends performance and service-based incentives to international employees, aligning global workforce compensation with company objectives. |
| Plan Amendment | First Amendment to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan, modifying share purchase limits and introducing a six-month holding period for purchased stock. | 2025-06-01 | Adjusts employee stock purchase program terms, potentially influencing employee participation and stock ownership, and aims to reduce short-term selling pressure on shares acquired through the plan. |
Legal Proceedings
- The company is involved in a lawsuit with BASF Corporation (the Delaware Proceeding) where a jury issued a verdict in favor of BASF for approximately $28.3 million, which was trebled to $85.0 million, for antitrust and tortious interference counterclaims.
- The court entered judgment on the jury's verdict on May 18, 2023.
- The company's motion seeking judgment as a matter of law or a new trial was denied on February 13, 2024.
- The company appealed the verdict and the dismissal of its patent infringement claims against BASF on March 13, 2024.
- As of June 30, 2025, the total amount accrued for the verdict and post-judgment interest is $93.4 million, reclassified to 'Current liabilities' as final resolution is expected within twelve months.
Stakeholder Impact
- Shareholders: Impacted by net losses and goodwill impairment, but also by improved Adjusted EBITDA and cash flow, and potential future profitability from repositioning efforts. The stock repurchase program remains available.
- Employees: The global workforce was reduced by 23%, with the Performance Chemicals segment experiencing a 40% reduction, due to repositioning actions and plant closures (DeRidder, Crossett). A management separation (S. Edward Woodcock) also occurred.
- Customers: Strategic repositioning in Performance Chemicals involves reducing exposure to lower-margin end-use markets (e.g., adhesives, publication inks, oilfield). Road construction customers were affected by unusually wet weather delays. Advanced Polymer Technologies customers faced impacts from tariffs and competitive pressures.
- Suppliers: The Crude Tall Oil (CTO) supply contract was terminated, reducing the company's volume requirements and exposure to CTO price fluctuations.
- Creditors: The company's total debt decreased, and it remains in compliance with all debt covenants, maintaining a strong liquidity position.
Next Steps
- Continue to monitor the evolving macroeconomic environment, including the impacts of recent tariffs and ongoing trade uncertainty.
- Manage the remaining $10 million to $15 million in cash charges associated with the Performance Chemicals repositioning during the remainder of 2025.
- Pursue all legal relief available to challenge the BASF lawsuit outcomes, with final resolution of appeals expected within 12 months of the balance sheet date.
- Begin contract renewal negotiations for the collective bargaining agreement at the Covington, Virginia Plant during the fourth quarter of 2025.
- Evaluate and consider purchases pursuant to the stock repurchase program, strategic acquisitions, joint ventures, or other transactions to create stockholder value and enhance financial performance.
- Potentially modify existing revolving credit facility, redeem outstanding senior notes, seek additional debt financing, or issue equity securities to fund future transactions or anticipated uses of cash.
Key Dates
| Date | Description |
|---|---|
| 2018-07-19 | Company filed suit against BASF Corporation (Delaware Proceeding). |
| 2019-02-14 | BASF asserted counterclaims against the company in the Delaware Proceeding. |
| 2020-11-18 | U.S. District Court dismissed the company's patent infringement claims. |
| 2021-09-15 | Jury in Delaware Proceeding issued a verdict in favor of BASF, awarding $28.3 million (trebled to $85.0 million). |
| 2022-07-25 | Board of Directors authorized repurchase of up to $500.0 million of common stock (2022 Authorization). |
| 2023-05-18 | Court in Delaware Proceeding entered judgment on the jury's verdict. |
| 2023-11-01 | Company announced strategic actions to reposition Performance Chemicals segment. |
| 2023-11 | Additional corporate and business cost reduction actions executed as part of Performance Chemicals repositioning. |
| 2024-02-13 | Court in Delaware Proceeding denied BASF's motion for pre-judgment interest and company's motion for judgment as a matter of law or new trial. |
| 2024-03-13 | Company appealed the verdict and dismissal of patent infringement claims against BASF. |
| 2024-07-01 | CTO supply contract terminated. |
| 2024-07 | Company announced plans to transition oleo-based product refining from Crossett, Arkansas to North Charleston, South Carolina. |
| 2024-12-01 | Collective bargaining agreement at Covington, Virginia Plant with Covington Paperworkers Union Local 675 expires. |
| 2024-12-31 | End of CTO resale activity. |
| 2025-01-01 | Pillar Two global minimum tax went into effect. |
| 2025-06-01 | First Amendment to the Amended and Restated 2017 Ingevity Corporation Employee Stock Purchase Plan effective. |
| 2025-06-30 | End of current Q2 and H1 period. |
| 2025-07-01 | S. Edward Woodcock's employment termination date. |
| 2025-07-04 | The 'One Big Beautiful Bill' (OBBB) signed into law. |
| 2025-08-01 | Common stock outstanding 36,466,285 shares. |
| 2025-08-05 | Filing date of the 10-Q. |
| 2026-09 | Open natural gas derivative contracts hedge a portion of forecasted transactions until this month. |
| 2027-12-31 | EBITDA Growth Performance Period and TSR Performance Period for PSUs end. |
Recommendation
holdThe company demonstrated improved Adjusted EBITDA and a substantial increase in cash flow from operations, largely driven by successful repositioning efforts in the Performance Chemicals segment and lower raw material costs. The upward revision of the full-year Adjusted EBITDA outlook is a positive signal. However, the significant non-cash goodwill impairment in the Advanced Polymer Technologies segment highlights ongoing challenges in that area, exacerbated by tariffs and competitive pressures. Additionally, the substantial accrued legal liability from the BASF lawsuit introduces a notable financial risk. Given these mixed signals—operational improvements offset by segment-specific weaknesses and legal overhang—a 'hold' recommendation is appropriate. Investors should monitor the sustained impact of strategic initiatives, the resolution of the legal proceedings, and the performance of the APT segment.
Keywords
Ingevity, NGVT, Quarterly Report, SEC Filing, Financial Results, Performance Materials, Performance Chemicals, Advanced Polymer Technologies, Goodwill Impairment, EBITDA, Net Sales, Cash Flow, Restructuring, Strategic Repositioning, Tariffs, BASF Lawsuit, Crude Tall Oil, CTO, Specialty Chemicals, Carbon Products, Pavement Technologies, Industrial Specialties, Corporate Governance, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.